many times i see people run into trouble when looking at both ta and fundamentals. with nvax at this stage, there is no fundamentals to speak of...losing money is the name of the game. selling products? years later. but that is the nature of the small biotech's fate.
however, the prospect and likelihood of ever being able to come out with products is alluring to many. it attracts a different breed of investors.
for india, the bf concern, among other health care issues, is real. this partnership makes sense on many levels.
to survive beyond the current stage for nvax is a big deal. it may not reflects on the pps, but it may stablized a new base at one dollar.
Well I hope you're right and you all make some $. Ultimately that is what we're all trying to do right? I will have my $$ elsewhere and will probably continue daytrading this 1. I have yet to hold a position in this stock overnight.